Authors show that after stopping hepatitis B therapy, off-treatment outcomes were linked to viral genotype and genomic ancestry rather than conventional ethnicity. Biologically grounded, granular ...

More than 300 million people globally have viral hepatitis. Predominantly caused by hepatitis A, B, and C viruses, viral hepatitis continues to confer high levels of morbidity and mortality despite ...

A comparative morphometric review calculates the structural and geometric parameters of hepatitis viruses to explore how ...

Results of a phase IIIb study found the direct-acting antiviral combination of glecaprevir/pibrentasvir to be highly effective and well tolerated in adults with acute ...

Before the Covid-19 pandemic, viral hepatitis killed more people in the United States than all 60 other reportable infectious diseases combined, including HIV, pneumonia, and tuberculosis. Which doesn ...

A community-based survey in Tolon, Ghana, revealed a 7.2 percent hepatitis B seroprevalence among adults, with significantly ...

Please provide your email address to receive an email when new articles are posted on . Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral ...

Jeff Lumfsden never had an inkling that something was wrong.

An international team of researchers has identified a promising new approach for treating infections with the Hepatitis E virus (HEV). At the center of the study is the drug Apilimod, which ...

Viral hepatitis is an infection of the liver with one of five strains of the hepatitis virus (A, B, C, D, or E), resulting in liver inflammation and damage. Hepatitis ...